id: NEW:non_invasive_fibrosis_test_score_to_liver_disease_mortality
name: Non-Invasive Fibrosis Test Score (FIB4/ELF/FibroScan/FibroTest) â†’ Liver Disease
  Mortality
from_node:
  node_id: NEW:non_invasive_fibrosis_test_score
  node_name: Non-Invasive Fibrosis Test Score (FIB4/ELF/FibroScan/FibroTest)
to_node:
  node_id: liver_disease_mortality
  node_name: Liver Disease Mortality
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Non-invasive tests (FIB4, ELF, FibroScan, FibroTest) measure biomarkers
  and physical properties of liver tissue that reflect underlying hepatic fibrosis
  severity'
- 'Step 2: Higher scores on these tests indicate more advanced liver fibrosis, which
  represents progressive replacement of functional hepatocytes with scar tissue'
- 'Step 3: Advanced fibrosis leads to impaired liver function, portal hypertension,
  and increased risk of hepatic decompensation'
- 'Step 4: Progressive fibrosis culminates in cirrhosis and end-stage liver disease,
  significantly elevating mortality risk from liver-related causes'
evidence:
  quality_rating: B
  n_studies: 11
  primary_citation: 'Freya A Rhodes et al. 2021. Systematic review: Investigating
    the prognostic performance of four non-invasive tests in alcohol-related liver
    disease. Journal of gastroenterology and hepatology.'
  supporting_citations: []
description: Non-invasive fibrosis tests predict liver disease mortality by measuring
  the degree of hepatic fibrosis, which is the strongest prognostic factor for mortality
  in chronic liver disease. Higher test scores indicate more advanced fibrosis and
  correspondingly higher mortality risk. In alcohol-related liver disease, all four
  major NITs (FIB4, ELF, FibroScan, FibroTest) demonstrated acceptable prognostic
  performance with AUROCs generally exceeding 0.7.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
moderators:
- name: test_type
  direction: strengthens
  strength: moderate
  description: ELF test showed highest AUROC range (0.72-0.85), followed by FIB4 (0.64-0.83),
    FibroTest (0.69-0.79), and FibroScan (0.65-0.76)
- name: alcohol_related_liver_disease
  direction: strengthens
  strength: moderate
  description: Evidence specifically validated in alcohol-related liver disease populations
    where fibrosis stage is the best mortality predictor
